Hyperthyroidism is associated with higher plasma endothelin-1 concentrations

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 1040-1043

  Chu, Chih Hsun ^a,b   Lee, Jenn Kuen ^a,b   Keng, Hsiu Man ^a   Chuang, Ming Ju ^a   Lu, Chih Chen ^a,b,c   Wang, Mei Chun ^a   Sun, Chun Chin ^a   Wei, Mei Chih ^a   Lam, Hing Chung ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

Author keywords

Endothelin 1; Graves' disease; HOMA R; Hyperthyroidism; Insulin resistance

Indexed keywords

ANTITHYROID AGENT; ENDOTHELIN 1; GLUCOSE; INSULIN; LIOTHYRONINE; THYROID HORMONE; THYROXINE;

ADULT; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; THYROID FUNCTION;

ADULT; ANTITHYROID AGENTS; CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; GRAVES DISEASE; HUMANS; INSULIN RESISTANCE; MALE; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 33744947048     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988.
2. Takahashi K, Jones PM, Kanse SM, Lam HC, Spokes RA, Ghatei MA, Bloom SR. Endothelin in the gastrointestinal tract: presence of endothelin-like immunoreactivity, endothelin-1 messenger ribonucleic acid, endothelin receptors and its pharmacological effect. Gastroenterology 99:1660-1667, 1990.
3. Takahashi K, Ghatei MA, Jones PM, Murphy JK, Lam HC, O'Halloran DJ, Bloom SR. Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endoclinol Metab 72:693-699, 1991.
4. Macrae AD, Bloom SR. Endothelin: an endocrine role. Trends Endocrinol Metab 3:153-157, 1992.
5. Colin I, Berbinschi A, Denef JF, Ketelslegers JM. Detection and identification of endothelin immunoreactivity in rat and porcine thyroid follicular cells. Endocrinology 130:544-546, 1992.
6. Tseng YC, Lahiri S, Jackson S, Burman KD, Wartofsky L. Endothelin binding to receptors and endothelin production by human thyroid follicular cells: effects of transforming growth factors and thyrotropin. J Clin Endoclinol Metab 76:156-161, 1993.
7. Eguchi K, Kawakami A, Nakashima M, Ida H, Sakito S, Sakai M, Terada K, Kawabe Y, Fukuda T, Ishikawa N. Stimulation of mitogenesis in human thyroid epithelial cells by endothelin. Acta Endocrinol 128:215-220, 1993.
8. Jackson S, Tseng YC, Lahiri S, Burman KD, Wartofsky L. Receptors for endothelin in cultured human thyroid cells and inhibition by endothelin of thyroglobulin secretion. J Clin Endoclinol Metab 75:388-392, 1992.
9. Miyakawa M, Tsushima T, Isozaki O, Demura H, Shizume K, Arai M. Endothelin stimulates c-fos mRNA expression and acts as a stimulator on cell proliferation of rat FRTL-5 thyroid cells. Biochem Biophys Res Commun 184:231-238, 1992.
10. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86:2863-2867, 1989.
11. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F. Presence of immunoreactive endothelin in human plasma. FEBS Lett 245:164-166, 1989.
12. Hemblein DM, Miller W, Cavero PG. Presence of endothelin in human and canine plasma (abstract). Am J Hypertens 4:211A, 1989.
13. Lam HC, Wang JP, Lee JK, Ho LT, Han TM, Lu CC, Chiang HT, Cheng DL, Bloom SR. The lung contents of endothelin are altered by thyroid hormone status in rat. Regul Peptides 3:33-39, 1993.
14. Lam HC, Lee JK, Lai KH, Chiang HT. Plasma endothelin levels are unaltered by thyroid hormone status in humans. J Cardiovasc Pharmacol 36(Suppl 1):S382-S385, 2000.
15. Letizia C, Centanni M, Cesareo R, De Ciocchis A, Cerci S, Scuro L, Fumarola A, D'Ambrosio C, Scavo D. Increased plasma levels of endothelin-1 in patients with hyperthyroidism. Metabolism 44:1239-1242, 1995.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and bcell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985.
17. Celik I, Akalin S, Erbas T. Serum levels of interleukin-6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. Eur J Endocrinol 132:668-672, 1995.
18. Komorowski J, Jankiewicz J, Robak T, Blasinska-Morawiec M, Stepien H. Cytokines serum levels as the markers of thyroid activation in Graves' disease. Immunol Lett 60:143-148, 1998.
19. Salvi M, Pedrazzoni M, Girasole G, Giuliani N, Minelli R, Wall JR, Roti E. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 143:197-202, 2000.
20. Senturk T, Kozaci LD, Kok F, Kadikoylu G, Bolaman Z. Proinflammatory cytokine levels in hyperthyroidism. Clin Invest Med 26:58-63, 2003.
21. Teplyakov AI. Endothelin-1 involved in systemic cytokine network inflammatory response at atherosclerosis. J Cardiovasc Pharmacol 44(Suppl 1):S274-S275, 2004.
22. Dimitriadis GD, Raptis SA. Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes 109(Suppl 2):S225-S239, 2001.